Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Jun 1;332(Pt 2):573–582. doi: 10.1042/bj3320573

Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2.

T Hayashi 1, M Usui 1, J Nishioka 1, Z X Zhang 1, K Suzuki 1
PMCID: PMC1219515  PMID: 9601089

Abstract

Protein C inhibitor (PCI) is the plasma inhibitor of activated protein C, which is the main protease of the anticoagulant protein C pathway. In this study the transcriptional regulation of human PCI gene in the human hepatoma cell line, HepG2, was characterized by evaluating the transient expression of a luciferase reporter gene. The 5' flanking region (residues -1587 to +2) of the PCI gene showed an adequate transcriptional activity, the maximum transcriptional activity being in a region between residues -452 and -94, which contains an Sp1-binding site, two AP2-binding sites and an inverted AP2-binding site. Transient expression assays with various deletion mutants and site-directed mutants showed that the Sp1-binding site (residues -302 to -294) has a potent promoter activity and that the upstream AP2-binding site (residues -350 to -343) has a potent enhancer activity; no activity was detected in the inverted (residues -413 to -404) and downstream (residues -136 to -127) AP2-binding sites. In addition, a region of the PCI gene (residues -452 to -414) containing the STATx-binding site, the A-activator (AA)-binding site, and the interferon alpha (IFN-alpha) response element, and another region of the PCI gene (residues -176 to -147) containing the GATA-1 and the IFN-gamma response element showed potent silencer activities. Gel mobility-shift assays with various DNA fragments indicated that the Sp1-binding site, the upstream AP2-binding site, the AA-binding site and the IFN-gamma response element interact with nuclear protein(s) of HepG2 cells. These findings suggest that the Sp1-binding site is the promoter, the AP2-binding site (residues -350 to -343) the enhancer, and both the AA-binding site and the IFN-gamma response element are the silencers of human PCI gene expression in HepG2 cells.

Full Text

The Full Text of this article is available as a PDF (620.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bao J. J., Sifers R. N., Kidd V. J., Ledley F. D., Woo S. L. Molecular evolution of serpins: homologous structure of the human alpha 1-antichymotrypsin and alpha 1-antitrypsin genes. Biochemistry. 1987 Dec 1;26(24):7755–7759. doi: 10.1021/bi00398a033. [DOI] [PubMed] [Google Scholar]
  2. Borellini F., Aquino A., Josephs S. F., Glazer R. I. Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 leukemia cells. Mol Cell Biol. 1990 Oct;10(10):5541–5547. doi: 10.1128/mcb.10.10.5541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Briggs M. R., Kadonaga J. T., Bell S. P., Tjian R. Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science. 1986 Oct 3;234(4772):47–52. doi: 10.1126/science.3529394. [DOI] [PubMed] [Google Scholar]
  4. Carter P. E., Dunbar B., Fothergill J. E. Genomic and cDNA cloning of the human C1 inhibitor. Intron-exon junctions and comparison with other serpins. Eur J Biochem. 1988 Apr 5;173(1):163–169. doi: 10.1111/j.1432-1033.1988.tb13980.x. [DOI] [PubMed] [Google Scholar]
  5. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dong G., Schulick A. H., DeYoung M. B., Dichek D. A. Identification of a cis-acting sequence in the human plasminogen activator inhibitor type-1 gene that mediates transforming growth factor-beta1 responsiveness in endothelium in vivo. J Biol Chem. 1996 Nov 22;271(47):29969–29977. doi: 10.1074/jbc.271.47.29969. [DOI] [PubMed] [Google Scholar]
  7. Donovan-Peluso M., George L. D., Hassett A. C. Lipopolysaccharide induction of tissue factor expression in THP-1 monocytic cells. Protein-DNA interactions with the promoter. J Biol Chem. 1994 Jan 14;269(2):1361–1369. [PubMed] [Google Scholar]
  8. Duan C., Clemmons D. R. Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J Biol Chem. 1995 Oct 20;270(42):24844–24851. doi: 10.1074/jbc.270.42.24844. [DOI] [PubMed] [Google Scholar]
  9. España F., Gilabert J., Estellés A., Romeu A., Aznar J., Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreted in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thromb Res. 1991 Nov 1;64(3):309–320. doi: 10.1016/0049-3848(91)90002-e. [DOI] [PubMed] [Google Scholar]
  10. Evans T., Reitman M., Felsenfeld G. An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc Natl Acad Sci U S A. 1988 Aug;85(16):5976–5980. doi: 10.1073/pnas.85.16.5976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fahrner J., Labruyere W. T., Gaunitz C., Moorman A. F., Gebhardt R., Lamers W. H. Identification and functional characterization of regulatory elements of the glutamine synthetase gene from rat liver. Eur J Biochem. 1993 May 1;213(3):1067–1073. doi: 10.1111/j.1432-1033.1993.tb17854.x. [DOI] [PubMed] [Google Scholar]
  12. Faisst S., Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 1992 Jan 11;20(1):3–26. doi: 10.1093/nar/20.1.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fernandez-Rachubinski F. A., Weiner J. H., Blajchman M. A. Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene. J Biol Chem. 1996 Nov 15;271(46):29502–29512. doi: 10.1074/jbc.271.46.29502. [DOI] [PubMed] [Google Scholar]
  14. Francis R. B., Jr, Thomas W. Behaviour of protein C inhibitor in intravascular coagulation and liver disease. Thromb Haemost. 1984 Aug 31;52(1):71–74. [PubMed] [Google Scholar]
  15. Geiser A. G., Busam K. J., Kim S. J., Lafyatis R., O'Reilly M. A., Webbink R., Roberts A. B., Sporn M. B. Regulation of the transforming growth factor-beta 1 and -beta 3 promoters by transcription factor Sp1. Gene. 1993 Jul 30;129(2):223–228. doi: 10.1016/0378-1119(93)90272-5. [DOI] [PubMed] [Google Scholar]
  16. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  17. Grange T., Roux J., Rigaud G., Pictet R. Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for C/EBP and a novel liver-specific nuclear factor. Nucleic Acids Res. 1991 Jan 11;19(1):131–139. doi: 10.1093/nar/19.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hayashi T., Suzuki K. Gene organization of human protein C inhibitor, a member of SERPIN family proteins encoded in five exons. Int J Hematol. 1993 Oct;58(3):213–224. [PubMed] [Google Scholar]
  19. Hermans J. M., Jones R., Stone S. R. Rapid inhibition of the sperm protease acrosin by protein C inhibitor. Biochemistry. 1994 May 10;33(18):5440–5444. doi: 10.1021/bi00184a012. [DOI] [PubMed] [Google Scholar]
  20. Hirosawa S., Nakamura Y., Miura O., Sumi Y., Aoki N. Organization of the human alpha 2-plasmin inhibitor gene. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6836–6840. doi: 10.1073/pnas.85.18.6836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Imagawa M., Chiu R., Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell. 1987 Oct 23;51(2):251–260. doi: 10.1016/0092-8674(87)90152-8. [DOI] [PubMed] [Google Scholar]
  22. Jackson S. P., MacDonald J. J., Lees-Miller S., Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell. 1990 Oct 5;63(1):155–165. doi: 10.1016/0092-8674(90)90296-q. [DOI] [PubMed] [Google Scholar]
  23. Kaling M., Kugler W., Ross K., Zoidl C., Ryffel G. U. Liver-specific gene expression: A-activator-binding site, a promoter module present in vitellogenin and acute-phase genes. Mol Cell Biol. 1991 Jan;11(1):93–101. doi: 10.1128/mcb.11.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kelsey G. D., Povey S., Bygrave A. E., Lovell-Badge R. H. Species- and tissue-specific expression of human alpha 1-antitrypsin in transgenic mice. Genes Dev. 1987 Apr;1(2):161–171. doi: 10.1101/gad.1.2.161. [DOI] [PubMed] [Google Scholar]
  25. Kingsley C., Winoto A. Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol. 1992 Oct;12(10):4251–4261. doi: 10.1128/mcb.12.10.4251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kumar A. P., Mar P. K., Zhao B., Montgomery R. L., Kang D. C., Butler A. P. Regulation of rat ornithine decarboxylase promoter activity by binding of transcription factor Sp1. J Biol Chem. 1995 Mar 3;270(9):4341–4348. doi: 10.1074/jbc.270.9.4341. [DOI] [PubMed] [Google Scholar]
  27. Laurell M., Christensson A., Abrahamsson P. A., Stenflo J., Lilja H. Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system. J Clin Invest. 1992 Apr;89(4):1094–1101. doi: 10.1172/JCI115689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Long G. L., Chandra T., Woo S. L., Davie E. W., Kurachi K. Complete sequence of the cDNA for human alpha 1-antitrypsin and the gene for the S variant. Biochemistry. 1984 Oct 9;23(21):4828–4837. doi: 10.1021/bi00316a003. [DOI] [PubMed] [Google Scholar]
  29. Loskutoff D. J., Linders M., Keijer J., Veerman H., van Heerikhuizen H., Pannekoek H. Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of introns. Biochemistry. 1987 Jun 30;26(13):3763–3768. doi: 10.1021/bi00387a004. [DOI] [PubMed] [Google Scholar]
  30. Meijers J. C., Chung D. W. Organization of the gene coding for human protein C inhibitor (plasminogen activator inhibitor-3). Assignment of the gene to chromosome 14. J Biol Chem. 1991 Aug 15;266(23):15028–15034. [PubMed] [Google Scholar]
  31. Meijers J. C., Kanters D. H., Vlooswijk R. A., van Erp H. E., Hessing M., Bouma B. N. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry. 1988 Jun 14;27(12):4231–4237. doi: 10.1021/bi00412a005. [DOI] [PubMed] [Google Scholar]
  32. Mizusawa S., Nishimura S., Seela F. Improvement of the dideoxy chain termination method of DNA sequencing by use of deoxy-7-deazaguanosine triphosphate in place of dGTP. Nucleic Acids Res. 1986 Feb 11;14(3):1319–1324. doi: 10.1093/nar/14.3.1319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Morito F., Saito H., Suzuki K., Hashimoto S. Synthesis and secretion of protein C inhibitor by the human hepatoma-derived cell line, Hep G2. Biochim Biophys Acta. 1985 Feb 21;844(2):209–215. doi: 10.1016/0167-4889(85)90092-8. [DOI] [PubMed] [Google Scholar]
  34. Perkins N. D., Edwards N. L., Duckett C. S., Agranoff A. B., Schmid R. M., Nabel G. J. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J. 1993 Sep;12(9):3551–3558. doi: 10.1002/j.1460-2075.1993.tb06029.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Prochownik E. V., Bock S. C., Orkin S. H. Intron structure of the human antithrombin III gene differs from that of other members of the serine protease inhibitor superfamily. J Biol Chem. 1985 Aug 15;260(17):9608–9612. [PubMed] [Google Scholar]
  36. Ragg H., Preibisch G. Structure and expression of the gene coding for the human serpin hLS2. J Biol Chem. 1988 Aug 25;263(24):12129–12134. [PubMed] [Google Scholar]
  37. Ray A., Gao X., Ray B. K. Role of a distal enhancer containing a functional NF-kappa B-binding site in lipopolysaccharide-induced expression of a novel alpha 1-antitrypsin gene. J Biol Chem. 1995 Dec 8;270(49):29201–29208. doi: 10.1074/jbc.270.49.29201. [DOI] [PubMed] [Google Scholar]
  38. Rezaie A. R., Cooper S. T., Church F. C., Esmon C. T. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem. 1995 Oct 27;270(43):25336–25339. doi: 10.1074/jbc.270.43.25336. [DOI] [PubMed] [Google Scholar]
  39. Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988 Jan 29;239(4839):487–491. doi: 10.1126/science.2448875. [DOI] [PubMed] [Google Scholar]
  40. Suzuki K., Deyashiki Y., Nishioka J., Kurachi K., Akira M., Yamamoto S., Hashimoto S. Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily. J Biol Chem. 1987 Jan 15;262(2):611–616. [PubMed] [Google Scholar]
  41. Suzuki K., Deyashiki Y., Nishioka J., Toma K. Protein C inhibitor: structure and function. Thromb Haemost. 1989 Jun 30;61(3):337–342. [PubMed] [Google Scholar]
  42. Suzuki K., Nishioka J., Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem. 1983 Jan 10;258(1):163–168. [PubMed] [Google Scholar]
  43. Suzuki K., Nishioka J., Kusumoto H., Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem. 1984 Jan;95(1):187–195. doi: 10.1093/oxfordjournals.jbchem.a134583. [DOI] [PubMed] [Google Scholar]
  44. Yang Z., Sugawara M., Ponath P. D., Wessendorf L., Banerji J., Li Y., Strominger J. L. Interferon gamma response region in the promoter of the human DPA gene. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9226–9230. doi: 10.1073/pnas.87.23.9226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ye R. D., Ahern S. M., Le Beau M. M., Lebo R. V., Sadler J. E. Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J Biol Chem. 1989 Apr 5;264(10):5495–5502. [PubMed] [Google Scholar]
  46. Yuan J., Wegenka U. M., Lütticken C., Buschmann J., Decker T., Schindler C., Heinrich P. C., Horn F. The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol Cell Biol. 1994 Mar;14(3):1657–1668. doi: 10.1128/mcb.14.3.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Zahedi K., Prada A. E., Davis A. E., 3rd Transcriptional regulation of the C1 inhibitor gene by gamma-interferon. J Biol Chem. 1994 Apr 1;269(13):9669–9674. [PubMed] [Google Scholar]
  48. Zhang D. E., Hetherington C. J., Tan S., Dziennis S. E., Gonzalez D. A., Chen H. M., Tenen D. G. Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem. 1994 Apr 15;269(15):11425–11434. [PubMed] [Google Scholar]
  49. Zhang J., Hagopian-Donaldson S., Serbedzija G., Elsemore J., Plehn-Dujowich D., McMahon A. P., Flavell R. A., Williams T. Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature. 1996 May 16;381(6579):238–241. doi: 10.1038/381238a0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES